We're not here to make a technical judgment on all aspects of the CETA. Of course there are some good aspects. Our job is to protect the health care system.
I was asked earlier about patents and intellectual property. There isn't a worse place to deal with patents and intellectual property than in trade negotiations. What we've been told by everybody close to the negotiations is that there's horse-trading, and we end up with bad patent policy because it was horse-traded for something in agriculture or something somewhere else. That's why we're saying that health care is too important to be a target for horse-trading for other sectors.
Those are the dynamics of international trade negotiations. It's not that there aren't some good parts to this. We're just saying that this is a flaw and we can fix it. We should fix it.